Parties
Company
Apotex Inc.
Company
Searchlight Pharma Inc.
On April 2, 2024, Apotex Inc., Canada's largest pharmaceutical company, acquired Searchlight Pharma Inc., a leading Canadian specialty pharmaceutical firm. The deal, expected to close in the second quarter of 2024, enhances Apotex's presence in the branded pharmaceuticals market, adding over 60 products to its portfolio. This acquisition aligns with Apotex's strategy to expand into branded pharmaceuticals, following its recent rights acquisition from Harrow, Inc. Searchlight, known for its growth and international market presence, will maintain its headquarters in Montreal, bolstering Apotex's operations in Quebec. Financial terms were not disclosed, but Deutsche Bank Securities Inc. and Goodmans LLP advised Apotex, while Bloom Burton Securities Inc. and Davies Ward Phillips & Vineberg advised Searchlight.
Deal Type
Merger & AcquisitionIndustry
HealthcareTransaction
Undisclosed/ConfidentialDeal Status
ClosedClosing Date
03 June 2024